← Leaderboards
Gregory C Shearer
Sanford Research/Usd
$3,012,630
Attributed
$5,472,712
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $711.2K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,472,712 · 5
By mechanism
R01$4,920,165 · 2
P20$552,547 · 3
Top collaborators
- Timothy Daniel O'Connell9 shared
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionFunctional DisorderCardiovascular DiseasesCardiacFibrosisFibroblastsIncidenceInterstitialNonesterified Fatty AcidsCoronary Heart DiseaseHeart FailureCohortDoseImproved OutcomeG-Protein-Coupled ReceptorsLong Chain Fatty AcidDietHeartCardiac MyocytesCell DeathFatty AcidsIschemiaEicosapentaenoic AcidMediating
Grant awards (12)
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$665,482
R01 · FY2024 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$679,062
R01 · FY2023 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$679,062
R01 · FY2022 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$678,416
R01 · FY2021 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$711,176
R01 · FY2020 · HL
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$374,874
R01 · FY2019 · HL
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$374,874
R01 · FY2018 · HL
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$373,031
R01 · FY2017 · HL
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$384,188
R01 · FY2016 · HL
ROLE OF LIPOTPROTEINS IN THE TRANSPORT AND ACTIO OF OXYLIPINS$223,825
P20 · FY2011 · RR · contact PI
SD COBRE: PHYSIOLOGY TESTING CORE$219,750
P20 · FY2011 · RR · contact PI
ROLE OF LIPOTPROTEINS IN THE TRANSPORT AND ACTIO OF OXYLIPINS$108,972
P20 · FY2010 · RR · contact PI